Experiment 1324790

Worktypes

PHARMACOLOGY OF COMPOUND - IN HUMANS

Compounds isolated

IBOGAINE,NOR:

Details

PropertyValue
Pharmacology
NARCOTIC WITHDRAWAL EFFECTS INHIBITION
OrganismEmpty organism
CitationGLUE,P: CAPE,G: TUNNICLIFF,D: LOCKHART,M:LAM,F: HUNG,N: HUNG,CT: HARLAND,S: DEVANE,J:CROCKETT,RS: HOWES,J: DARPO,B: ZHOU,MJ: WEIS,H: FRIEDHOFF,L:. (2016). ASCENDING SINGLE-DOSE, DOUBLE-BLIND,PLACEBO-CONTROLLED SAFETY STUDY OFNORIBOGAINE IN OPIOID-DEPENDENT PATIENTS. 5(6)
Amount utilized
Compound isolated
DiseaseOPIOID WITHDRAWAL SYMPTOMS WERE EVALUATED BY PUPILLOMETRY AND SUBJECTIVE AND OBJECTIVE RATING SCALES AND ALSO RECORDED THE TIME AT WHICH PARTICIPANTS REQUESTED TO RESTART OPIOID SUBSTITUTION TREATMENT.
Dose amount60-180 MG
Number3
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE